December 3 - 6, 2014
Royal Continental Hotel
Naples, Italy
This meeting was jointly organized by Istituto Nazionale Tumori Fondazione "G. Pascale," Fondazione Melanoma Onlus and Sidra Medical and Research Center, together with the Society for Immunotherapy of Cancer (SITC).
The Scientific Board of Melanoma Bridge, including well-known experts covering different areas and based in different Countries, aims at achieving a broad-based participation by various groups and societies sharing a clinical or basic interest in the immunology and the biology of the cancer microenvironment.
The scientific program of the meeting will be organized in 6 sessions:
Molecular and Immuno advances:
1. Combination therapies;
2. News in Immunotherapy;
3. Tumor microenvironment and biomarkers;
4. World-Wide Immunoscore Task Force: an update
5. Round Table on regulatory issues of melanoma drugs
Attendees are expected from all around the world and encouraged to submit abstracts for poster or oral presentation during the event. All accepted abstracts will be included in a dedicated Supplement of the Journal of Translational Medicine. The speaker of the abstracts selected for oral communication will be exempt from registration fee and invited as speakers to Naples.
As traditional at Melanoma Bridge, representatives of melanoma patient associations will have their chance to actively join the event. For more information, visit: www.melanomabridge.org/